Correction: Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in

Bojana Lazovic1,2,3, Hoang-Tuan Nguyen3,4, Mohammadhassan Ansarizadeh3

  • 1BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Angiogenesis
|June 26, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos